Compare AMPH & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPH | AHCO |
|---|---|---|
| Founded | 1996 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.5B |
| IPO Year | 2005 | 2017 |
| Metric | AMPH | AHCO |
|---|---|---|
| Price | $19.47 | $10.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $30.29 | $13.25 |
| AVG Volume (30 Days) | 597.8K | ★ 1.5M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.03 | N/A |
| Revenue | $719,887,000.00 | ★ $3,244,857,000.00 |
| Revenue This Year | $7.34 | $9.00 |
| Revenue Next Year | $4.81 | $6.93 |
| P/E Ratio | $9.63 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.03 | $7.11 |
| 52 Week High | $31.26 | $11.17 |
| Indicator | AMPH | AHCO |
|---|---|---|
| Relative Strength Index (RSI) | 36.15 | 51.93 |
| Support Level | $17.03 | $8.67 |
| Resistance Level | $29.30 | $10.62 |
| Average True Range (ATR) | 0.90 | 0.46 |
| MACD | 0.02 | 0.10 |
| Stochastic Oscillator | 61.19 | 58.51 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.